Business Process Outsourcing

PRODUCTS

  • Facility Design For Pharmaceutical Manufacturing Operations

    Using our integrated EPCMV process allows us to deliver exceptional manufacturing facilities to the clients we serve. We understand the complex nature of the systems and structures in the facilities we produce. From bioreactors to powder transfer systems, cosmetics to medical devices, we are at the forefront of the latest advances in the industry. Our approach takes a holistic view of each project. We provide the latest, proven concepts to deliver exceptional results for the clients we serve.

  • Patient Engagement

    WCG’s end-to-end patient recruitment solution connects patients to clinical trials, enhances site resources and capabilities, and improves study data quality and endpoints. On average, we are helping our clients achieve a 33% acceleration in their enrollment timelines.

  • FlexNet EasyLink™ Radio Reader

    The FlexNet EasyLink™ Reader is a portable, radio-based device used to acquire data from utility meters that utilize Sensus SmartPoint® modules and/or Itron ERT radios. The Reader is compact and portable, allowing it to be used in any vehicle providing 12-volt DC power.

  • Dry ESP Alternative

    When are ceramic filters the best-available technology?

  • OPTISONIC 6300 P Ultrasonic Clamp-On Flowmeter

    The OPTISONIC 6300 P is a portable, battery-powered ultrasonic clamp-on flowmeter for temporary flow measurement of (non-)conductive liquids. It can be used at virtually any location and without process interruption or need to cut pipes. Due to its flexibility, the meter is equally suited for comparative measurements on stationary measuring equipment (e.g. pumps, flowmeters etc.) or for use as a short-term replacement of faulty devices. As standard the clamp-on flowmeter is also provided with a measurement option for thermal energy applications.

WHITE PAPERS AND CASE STUDIES

  • CRO Implements A Successful, Patient-Centric Decentralized Solution For An On-going Clinical Trial During COVID-19

    A mid-sized biotech company was in the middle of conducting an open-label long-term safety study with 137 active patients across 25 sites in the US and Canada. Then the COVID-19 pandemic hit. Rho developed a customized and decentralized solution for their study that would ensure patient safety and data quality while allowing their study to progress according to FDA guidelines for conducting research during this pandemic.

  • Simple SOP Updates Every Research Site Needs To Succeed At Remote Monitoring

    Today’s crisis climate is creating a dichotomy in clinical research. As a result, sites are closing, medical facilities are enforcing access restrictions, and there are constant delays or stoppage of non-essential studies. On the other hand, this health crisis is highlighting the critical need for clinical research due to ongoing COVID-19 trials. As a result, clinical researchers are asking questions and seeking workarounds to continue operations in response to site-specific adjustments. One central issue has surfaced — how do we continue to maintain compliance when working from home?

  • Building An Online Platform To Fight Counterfeits On Blockchain

    Blockchain technology can be used to build an online platform where manufacturers, retailers, and consumers can come together to authenticate goods that we buy every day. A startup company plans to scale up by working with its manufacturing and retailing partners and building up the platform to fight counterfeit issues and show authentic supply chain information on the blockchain. This would ultimately drive out the counterfeits in the retail supply chain and afford a satisfying shopping experience.

  • Droplet Digital Polymerase Chain Reaction

    Leveraging the hyper accuracy of Droplet Digital PCR (ddPCR), viral and gene therapy developers gain additional confidence in tittering assays and vector copy number determination.

  • Three Options To Viral Vector Manufacturing Capacity

    Industry thought leaders working in the viral vector manufacturing space recently participated in a Virtual Think Tank (VTT), a unique thought leadership platform that brings together leading minds, to discuss viral vector manufacturing facility design. The focus of the most recent VTT was on the current challenges and trends influencing design considerations for viral vector manufacturing facilities and how they can impact companies developing cell and gene therapies.

  • Utilizing External Collaboration To Accelerate Vaccine Development

    Securing a partner to serve as an extension of Janssen’s Biotherapeutics Development API-Large Molecule team was essential to reduce both risk and the time needed for delivery of clinical supplies.

  • The Hanor Family Of Companies: Companies Running Faster And Leaner With DocStar

    To enhance efficiencies companywide, Hanor went live with the DocStar Enterprise Content Management (ECM) system with advanced workflow, reporting, and intelligent data capture in March 2017. After more than two years of shopping around, the program was selected primarily for its ability to improve productivity through enhanced interdepartmental collaboration, as well as eliminate time-consuming manual processes.

  • Leveraging Expertise To Exceed Immunotherapy Customer Goals

    A biologics company needed a CRO with a dedicated oncology team to manage its Phase I, multi-center study to evaluate the safety and pharmacokinetic (PK) profile of an immunotherapeutic drug in subjects with advanced solid tumors. They found a clinical trial partner with oncology experience that could support protocol design and accelerate the start-up process to meet a quick first-patient-in (FPI) milestone.

  • ICH Q12 Updates: Increasing Efficiency Of Post-Approval Changes

    Through proper implementation of ICH Q12 tools and enablers, the industry could manage CMC changes effectively under a company’s pharma quality system with less need for oversight prior to implementation.

  • How A Top CRO Used ClinCard To Create A Personalized Patient Experience For A Non-interventional Psoriasis Study

    The CRO realized that they needed to introduce new ways to keep participants engaged and interested if they were going to successfully support this trial. The CRO identified ClinCard as the ideal software that could instantly get study participants their stipends, without adding a burden on the site staff.

  • Texas Cardiology Research Department Transforms Document Access, Fuels Productivity

    What drives an established and experienced clinical research site to completely transform the way they manage regulatory and trial documentation? For South Texas Cardiovascular Consultants, PLLC (STCC) it wasn’t just about paper, it was about what paper forced us to do.

  • Large PMA Study Of CRC Diagnostic

    A study needed to enroll approximately 12,000 subjects and was also unique because it required subjects to self-collect samples at home. Read about the risk management and mitigation that Health Decisions utilized to keep the study on track.

NEWS